Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 71

Related Citations for PubMed (Select 19864622)

1.

Chemical reversal of the RNA gain of function in myotonic dystrophy.

Cooper TA.

Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18433-4. doi: 10.1073/pnas.0910643106. Epub 2009 Oct 28. No abstract available.

2.

Pentamidine reverses the splicing defects associated with myotonic dystrophy.

Warf MB, Nakamori M, Matthys CM, Thornton CA, Berglund JA.

Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18551-6. doi: 10.1073/pnas.0903234106. Epub 2009 Oct 12.

3.

Gain of RNA function in pathological cases: Focus on myotonic dystrophy.

Klein AF, Gasnier E, Furling D.

Biochimie. 2011 Nov;93(11):2006-12. doi: 10.1016/j.biochi.2011.06.028. Epub 2011 Jul 13. Review.

PMID:
21763392
4.

A reversal of misfortune for myotonic dystrophy?

Cooper TA.

N Engl J Med. 2006 Oct 26;355(17):1825-7. No abstract available.

PMID:
17065646
5.

Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy.

Mankodi A, Takahashi MP, Jiang H, Beck CL, Bowers WJ, Moxley RT, Cannon SC, Thornton CA.

Mol Cell. 2002 Jul;10(1):35-44.

PMID:
12150905
6.

Molecular biology. Neutralizing toxic RNA.

Cooper TA.

Science. 2009 Jul 17;325(5938):272-3. doi: 10.1126/science.1177452. No abstract available.

PMID:
19608901
7.

Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy.

Wang GS, Kearney DL, De Biasi M, Taffet G, Cooper TA.

J Clin Invest. 2007 Oct;117(10):2802-11.

8.

Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1.

Hino S, Kondo S, Sekiya H, Saito A, Kanemoto S, Murakami T, Chihara K, Aoki Y, Nakamori M, Takahashi MP, Imaizumi K.

Hum Mol Genet. 2007 Dec 1;16(23):2834-43. Epub 2007 Aug 29.

9.

Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.

Ranum LP, Day JW.

Curr Neurol Neurosci Rep. 2002 Sep;2(5):465-70. Review.

PMID:
12169228
10.

Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small molecules.

Childs-Disney JL, Stepniak-Konieczna E, Tran T, Yildirim I, Park H, Chen CZ, Hoskins J, Southall N, Marugan JJ, Patnaik S, Zheng W, Austin CP, Schatz GC, Sobczak K, Thornton CA, Disney MD.

Nat Commun. 2013;4:2044. doi: 10.1038/ncomms3044.

11.

Nuclear RNA foci in the heart in myotonic dystrophy.

Mankodi A, Lin X, Blaxall BC, Swanson MS, Thornton CA.

Circ Res. 2005 Nov 25;97(11):1152-5. Epub 2005 Oct 27.

12.

Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.

Ho TH, Savkur RS, Poulos MG, Mancini MA, Swanson MS, Cooper TA.

J Cell Sci. 2005 Jul 1;118(Pt 13):2923-33. Epub 2005 Jun 16.

13.

[From gene to disease; altered RNA processing as a cause of myotonic dystrophy type 1].

de Die-Smulders CE, Faber CG, Smeets HJ.

Ned Tijdschr Geneeskd. 2005 Sep 10;149(37):2043-6. Review. Dutch. Erratum in: Ned Tijdschr Geneeskd. 2005 Oct 8;149(41):2316.

PMID:
16184945
14.

[Myotonic dystrophy: therapeutic approaches to RNA toxicity].

Nakamori M, Takahashi MP.

Brain Nerve. 2011 Nov;63(11):1161-8. Review. Japanese.

PMID:
22068468
15.

Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA.

Wheeler TM, Sobczak K, Lueck JD, Osborne RJ, Lin X, Dirksen RT, Thornton CA.

Science. 2009 Jul 17;325(5938):336-9. doi: 10.1126/science.1173110.

16.

Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs.

Yuan Y, Compton SA, Sobczak K, Stenberg MG, Thornton CA, Griffith JD, Swanson MS.

Nucleic Acids Res. 2007;35(16):5474-86. Epub 2007 Aug 15.

17.

RNA-dominant diseases.

Osborne RJ, Thornton CA.

Hum Mol Genet. 2006 Oct 15;15 Spec No 2:R162-9. Review.

18.

Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy.

Philips AV, Timchenko LT, Cooper TA.

Science. 1998 May 1;280(5364):737-41.

19.

Myotonic dystrophy mouse models: towards rational therapy development.

Gomes-Pereira M, Cooper TA, Gourdon G.

Trends Mol Med. 2011 Sep;17(9):506-17. doi: 10.1016/j.molmed.2011.05.004. Epub 2011 Jul 2. Review.

20.

Myotonic dystrophy: RNA-mediated muscle disease.

Wheeler TM, Thornton CA.

Curr Opin Neurol. 2007 Oct;20(5):572-6. Review.

PMID:
17885447
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk